Bayer CropScience and Mendel Biotechnology, Inc. in Hayward, California (USA) have entered into a new three-year collaboration agreement which extends their existing joint activities.

The objective is to develop chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity.

Bayer CropScience is contributing its expertise in chemical research – specifically in substance screening – to this collaboration. The company is already marketing products which enhance the stress tolerance of plants and boost yields under the “Stress Shield Inside” label. Mendel, a pioneer in plant functional genomics has a large number of biotechnology patents. Mendel researchers have identified key genes responsible for controlling plant growth and environmental responses and are applying these discoveries to improve plant performance.

The research program focuses on new approaches to improving crop productivity. The aim is to develop substances which chemically modulate the signaling networks used by plants to control parameters such as growth and stress tolerance. Mendel and Bayer have already worked together for several years in the discovery and development of chemical products to regulate plant stress tolerance. This partnership will now be extended to include the discovery of substances which regulate additional components of crop yield potential.

“Chemical products that mediate enhanced crop performance are an untapped market with potentially high added value,” commented Dr. Alexander Klausener, Head of Research at Bayer CropScience. “New solutions would enable Bayer CropScience to make a significant contribution to safeguarding agricultural yields and increasing productivity in the longer term. Although abiotic stress factors cause substantial loss of yields in agriculture, the development of products to strengthen plants and increase yields is a largely uncharted field of research.”

“We have been collaborating with Bayer CropScience for a number of years and have built an excellent working relationship with their scientific team,” said Oliver J. Ratcliffe, Mendel’s Vice President of Research. “This new program now provides the opportunity to expand our chemical research into additional valuable areas. The partnership offers significant synergies and leverages both Mendel’s knowledge and advanced technology platforms for analysis of gene regulation as well as the expertise of Bayer CropScience as one of the world´s leading innovative companies in the agricultural industry."

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.5 billion (2009), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 18,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

About Mendel Technology

Mendel Biotechnology, Inc. is a leader in the application of functional genomics to the study of plant genes. Mendel has identified genes that control many aspects of plant growth and development, and is working to develop or co-develop new plant varieties with improved productivity and quality. Mendel has relationships with leading agricultural, energy, forestry and horticulture companies for the commercialization of improved seed and plant products, and is developing its own seed and feedstock products for the emerging bioenergy market. For more information, visit: www.mendelbio.com.

Your contact:

Bayer CropScience
Utz Klages, Phone +49 2173 38-3125
E-Mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Mendel Biotechnology, Inc.
Oliver J. Ratcliffe, Vice President, Research, Phone +1 510 264-0280

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Source: Bayer CropScience